These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 8886604

  • 1. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
    Ekström G, Gunnarsson UB.
    Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
    [Abstract] [Full Text] [Related]

  • 2. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes.
    Postlind H, DanielsonA, Lindgren A, Andersson SH.
    Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513
    [Abstract] [Full Text] [Related]

  • 3. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.
    Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y.
    Anesthesiology; 1995 Jan; 82(1):214-20. PubMed ID: 7832304
    [Abstract] [Full Text] [Related]

  • 5. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
    Mäenpää J, Hall SD, Ring BJ, Strom SC, Wrighton SA.
    Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of phencyclidine by human liver microsomes.
    Laurenzana EM, Owens SM.
    Drug Metab Dispos; 1997 May; 25(5):557-63. PubMed ID: 9152594
    [Abstract] [Full Text] [Related]

  • 7. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
    Jönsson G, Aström A, Andersson P.
    Drug Metab Dispos; 1995 Jan; 23(1):137-42. PubMed ID: 7720517
    [Abstract] [Full Text] [Related]

  • 8. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK.
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [Abstract] [Full Text] [Related]

  • 9. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M, Shindo M, Shimada T.
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A.
    Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, Lacarelle B, Hardwigsen J, Le-Treut YP.
    Drug Metab Dispos; 2000 Apr; 28(4):383-5. PubMed ID: 10725304
    [Abstract] [Full Text] [Related]

  • 12. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A, Satoh H, Thomas PE, Bush E, Moore D.
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [Abstract] [Full Text] [Related]

  • 13. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.
    Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, Hall SD.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolism and excretion of ropivacaine in humans.
    Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M.
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.
    Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM, Prough RA.
    Arch Biochem Biophys; 2001 May 15; 389(2):278-87. PubMed ID: 11339818
    [Abstract] [Full Text] [Related]

  • 18. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y, Guo X, Lin ET, Benet LZ.
    Drug Metab Dispos; 1998 Apr 15; 26(4):360-6. PubMed ID: 9531525
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
    Klees TM, Sheffels P, Dale O, Kharasch ED.
    Drug Metab Dispos; 2005 Mar 15; 33(3):303-11. PubMed ID: 15557344
    [Abstract] [Full Text] [Related]

  • 20. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H, White RB, Stevens JC.
    Drug Metab Dispos; 1996 Sep 15; 24(9):948-54. PubMed ID: 8886603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.